Estrogen and tumors: For better or for worse? [3]

Science

Volumn 318, Issue 5854, 2007, Pages 1239-1240

  Van Der Windt, Dirk J ^a   Kok, Niels F M ^a   Ijzermans, Jan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; INTERLEUKIN 6; ORAL CONTRACEPTIVE AGENT; TAMOXIFEN;

CANCER RISK; CLINICAL TRIAL; COMPARATIVE STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG MECHANISM; HEPATITIS B; HEPATITIS C; HUMAN; LETTER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE DRUG DOSE;

EID: 36448985603     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.318.5854.1239c     Document Type: Letter

References (4)

1. Cancer of the Liver Italian Programme, Lancet 352, 17 (1998).
2. H. A. Edmondson, B. Henderson, B. Benton, N. Engl. J. Med. 294, 470 (1976).
3. E. A. Psatha et al., J. Magn. Reson. Imag. 22, 258 (2005).
4. D. J. van der Windt et al., Br. J. Surg. 93, 1495 (2006).